Fucoidan elevated the expression of HLA-DR and co-stimulatory molecules of DCs, induces their Th1-promoting tumor necrosis factor α (TNF-α) and interleukin-12 (IL-12) secretion. This fucoidan is suggested to be used in DC-based vaccines for cancer immunotherapy. The gene discussed is TNF; the disease is cancer.